Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Preclinical CRO market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Preclinical CRO market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Preclinical CRO market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Preclinical CRO products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Preclinical CRO products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Preclinical CRO market.
To learn more about this report
Increasing research and development spending on Preclinical CRO development has been the leading industry trend of Preclinical CRO market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
Report Attributes | Details |
The market size value in 2021 | USD XX.XX Million |
CAGR (2021 - 2028) | XX.XX % |
The Revenue forecast in 2028 | USD XX.XX Million |
Base year for estimation | 2021 |
Historical data | 2018-2019 |
Forecast period | 2022-2028 |
Quantitative units |
|
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
By Service Outlook | Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others |
By End-use Outlook | Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies |
Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled | Envigo Corp., MPI Research, Eurofins Scientific, PRA Health Sciences, Inc., Wuxi AppTec, Medpace, Inc., Pharmaceutical Product Development (PPD), LLC, PARAXEL International Corp., ICON Plc, Laboratory Corporation of America, Inc. |
Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Preclinical CRO Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Preclinical CRO Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Preclinical CRO Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Preclinical CRO Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Bioanalysis and DMPK studies
4.2.2 Toxicology Testing
4.2.3 Compound Management
4.2.4 Chemistry
4.2.5 Safety Pharmacology
4.4 Type Comparison Matrix
4.5 Global Preclinical CRO Market Attractiveness, By Type
5 Global Preclinical CRO Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Preclinical CRO Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Biopharmaceutical Companies
5.3.2 Government and Academic Institutes
5.3.3 Medical Device Companies
5.3.4 Other
5.4 Application Comparison Matrix
5.5 Global Preclinical CRO Market Attractiveness, by Application
6 Global Preclinical CRO Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Preclinical CRO Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Preclinical CRO Market Attractiveness, by Region
8 North America Preclinical CRO Market Analysis and Forecast
8.1 Key Findings
8.2 North America Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Bioanalysis and DMPK studies
8.2.2 Toxicology Testing
8.2.3 Compound Management
8.2.4 Chemistry
8.2.5 Safety Pharmacology
8.3 North America Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Biopharmaceutical Companies
8.3.2 Government and Academic Institutes
8.3.3 Medical Device Companies
8.3.4 Other
8.4 North America Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Preclinical CRO Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Preclinical CRO Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Bioanalysis and DMPK studies
9.2.2 Toxicology Testing
9.2.3 Compound Management
9.2.4 Chemistry
9.2.5 Safety Pharmacology
9.3 Europe Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Biopharmaceutical Companies
9.3.2 Government and Academic Institutes
9.3.3 Medical Device Companies
9.3.4 Other
9.4 Europe Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Preclinical CRO Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Preclinical CRO Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Bioanalysis and DMPK studies
10.2.2 Toxicology Testing
10.2.3 Compound Management
10.2.4 Chemistry
10.2.5 Safety Pharmacology
10.3 Asia Pacific Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Biopharmaceutical Companies
10.3.2 Government and Academic Institutes
10.3.3 Medical Device Companies
10.3.4 Other
10.4 Asia Pacific Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Preclinical CRO Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Preclinical CRO Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Bioanalysis and DMPK studies
11.2.2 Toxicology Testing
11.2.3 Compound Management
11.2.4 Chemistry
11.2.5 Safety Pharmacology
11.3 Latin America Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Biopharmaceutical Companies
11.3.2 Government and Academic Institutes
11.3.3 Medical Device Companies
11.3.4 Other
11.4 Latin America Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Preclinical CRO Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Preclinical CRO Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Bioanalysis and DMPK studies
12.2.2 Toxicology Testing
12.2.3 Compound Management
12.2.4 Chemistry
12.2.5 Safety Pharmacology
12.3 Middle East & Africa (MEA) Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Biopharmaceutical Companies
12.3.2 Government and Academic Institutes
12.3.3 Medical Device Companies
12.3.4 Other
12.4 Middle East & Africa (MEA) Preclinical CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Preclinical CRO Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Envigo Corp.
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 MPI Research
13.3.3 Eurofins Scientific
13.3.4 PRA Health Sciences
13.3.5 Inc.
13.3.6 Wuxi AppTec
13.3.7 Medpace
13.3.8 Inc.
13.3.9 Pharmaceutical Product Development (PPD)
13.3.10 LLC
13.3.11 PARAXEL International Corp.
13.3.12 ICON Plc
13.3.13 Laboratory Corporation of America
13.3.14 Inc.
14 Key Takeaways
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing